» Articles » PMID: 16825529

Poly(ADP-ribose) Glycohydrolase Activity Mediates Post-traumatic Inflammatory Reaction After Experimental Spinal Cord Trauma

Overview
Specialty Pharmacology
Date 2006 Jul 11
PMID 16825529
Citations 8
Authors
Affiliations
Soon will be listed here.
Abstract

The aim of the present study was to examine the role of poly-(ADP-ribose) glycohydrolase (PARG) on the modulation of the inflammatory response and tissue injury associated with neurotrauma. Spinal cord trauma was induced in wild-type (WT) mice by the application of vascular clips (force of 24 g) to the dura via a two-level T(6) to T(7) laminectomy. Spinal cord injury in WT mice resulted in severe trauma characterized by edema, neutrophil infiltration, and cytokine production followed by recruitment of other inflammatory cells, production of a range of inflammation mediators, tissue damage, apoptosis, and disease. The genetic disruption of the PARG gene in mice or the pharmacological inhibition of PARG with GPI 16552 [N-bis-(3-phenyl-propyl)9-oxo-fluorene-2,7-diamide] (40 mg/kg i.p. bolus), a novel and potent PARG inhibitor, significantly reduced the degree of spinal cord inflammation and tissue injury (histological score), neutrophil infiltration, cytokine production (tumor necrosis factor-alpha and interleukin-1beta), and apoptosis. In a separate experiment, we have clearly demonstrated that PARG inhibition significantly ameliorated the recovery of limb function. Taken together, our results indicate that PARG activity modulates the inflammatory response and tissue injury events associated with spinal cord trauma and participate in target organ damage under these conditions.

Citing Articles

ADP-ribose hydrolases: biological functions and potential therapeutic targets.

Wang J, Wang Z, Zong W Expert Rev Mol Med. 2024; 26:e21.

PMID: 39375922 PMC: 11488344. DOI: 10.1017/erm.2024.17.


PARG suppresses tumorigenesis and downregulates genes controlling angiogenesis, inflammatory response, and immune cell recruitment.

Johnson S, Karpova Y, Guo D, Ghatak A, Markov D, Tulin A BMC Cancer. 2022; 22(1):557.

PMID: 35585513 PMC: 9118775. DOI: 10.1186/s12885-022-09651-9.


Co-Ultramicronized Palmitoylethanolamide/Luteolin Promotes Neuronal Regeneration after Spinal Cord Injury.

Crupi R, Impellizzeri D, Bruschetta G, Cordaro M, Paterniti I, Siracusa R Front Pharmacol. 2016; 7:47.

PMID: 27014061 PMC: 4782663. DOI: 10.3389/fphar.2016.00047.


Beyond DNA repair, the immunological role of PARP-1 and its siblings.

Rosado M, Bennici E, Novelli F, Pioli C Immunology. 2013; 139(4):428-37.

PMID: 23489378 PMC: 3719060. DOI: 10.1111/imm.12099.


Selective adenosine A2A receptor agonists and antagonists protect against spinal cord injury through peripheral and central effects.

Paterniti I, Melani A, Cipriani S, Corti F, Mello T, Mazzon E J Neuroinflammation. 2011; 8:31.

PMID: 21486435 PMC: 3096915. DOI: 10.1186/1742-2094-8-31.